The Impact of COVID-19 is included in Pediatric Vaccine Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Pediatric Vaccine Trends and Forecast
The future of the global pediatric vaccine market looks promising with opportunities in the infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, and mumps, and rubella (MMR) applications. The global pediatric vaccine market is expected to reach an estimated $30.8 billion by 2030 with a CAGR of 5.7% from 2024 to 2030. The major drivers for this market are rising awareness of the benefits of these vaccines among parents and medical professionals, growing demand for combination vaccines, and continous development of new and innovative pediatric vaccines.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Pediatric Vaccine by Segment
The study includes a forecast for the global pediatric vaccine by vaccine type, technology, application, and region.
Pediatric Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:
• Monovalent
• Multivalent
Pediatric Vaccine Market by Technology [Shipment Analysis by Value from 2018 to 2030]:
• Live Attenuated
• Inactivated
• Subunit
• Toxoid
• Conjugate
• Others
Pediatric Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Infectious Disease
• Cancer
• Allergy
• Pneumococcal Disease
• Influenza
• Measles, Mumps, and Rubella (Mmr)
• Others
Pediatric Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Pediatric Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pediatric vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pediatric vaccine companies profiled in this report include-
• Glaxosmithkline
• Merck & Co
• Sanofi
• Pfizer
• Johnson & Johnson
• Bharat Biotech International
• Serum Institute Of India
Pediatric Vaccine Market Insights
Lucintel forecasts that conjugate is expected to witness highest growth over the forecast period due to its significant usage in pneumococcal and meningococcal diseases to provide restraining power against these viruses.
North America is expected to witness highest growth over the forecast period due to existence of robust healthcare infrastructure, supportive government initiative for immunization programs, and growing of pediatric population in the region.
Features of the Global Pediatric Vaccine Market
Market Size Estimates: Pediatric vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Pediatric vaccine market size by vaccine type, technology, application, and region in terms of value ($B).
Regional Analysis: Pediatric vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different vaccine types, technologies, applications, and regions for the pediatric vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pediatric vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the pediatric vaccine market size?
Answer: The global pediatric vaccine market is expected to reach an estimated $30.8 billion by 2030.
Q.2 What is the growth forecast for pediatric vaccine market?
Answer: The global pediatric vaccine market is expected to grow with a CAGR of 5.7% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the pediatric vaccine market?
Answer: The major drivers for this market are rising awareness of the benefits of these vaccines among parents and medical professionals, growing demand for combination vaccines, and continous development of new and innovative pediatric vaccines.
Q4. What are the major segments for pediatric vaccine market?
Answer: The future of the pediatric vaccine market looks promising with opportunities in the infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, and mumps, and rubella (MMR) applications.
Q5. Who are the key pediatric vaccine market companies?
Answer: Some of the key pediatric vaccine companies are as follows:
• Glaxosmithkline
• Merck & Co
• Sanofi
• Pfizer
• Johnson & Johnson
• Bharat Biotech International
• Serum Institute Of India
Q6. Which pediatric vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that conjugate is expected to witness highest growth over the forecast period due to its significant usage in pneumococcal and meningococcal diseases to provide restraining power against these viruses.
Q7. In pediatric vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to existence of robust healthcare infrastructure, supportive government initiative for immunization programs, and growing of pediatric population in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the pediatric vaccine market by vaccine type (monovalent and multivalent), technology (live attenuated, inactivated, subunit, toxoid, conjugate, and others), application (infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, mumps, and rubella (MMR), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Pediatric Vaccine Market, Pediatric Vaccine Market Size, Pediatric Vaccine Market Growth, Pediatric Vaccine Market Analysis, Pediatric Vaccine Market Report, Pediatric Vaccine Market Share, Pediatric Vaccine Market Trends, Pediatric Vaccine Market Forecast, Pediatric Vaccine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Pediatric Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Pediatric Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Pediatric Vaccine Market by Vaccine Type
3.3.1: Monovalent
3.3.2: Multivalent
3.4: Global Pediatric Vaccine Market by Technology
3.4.1: Live Attenuated
3.4.2: Inactivated
3.4.3: Subunit
3.4.4: Toxoid
3.4.5: Conjugate
3.4.6: Others
3.5: Global Pediatric Vaccine Market by Application
3.5.1: Infectious Disease
3.5.2: Cancer
3.5.3: Allergy
3.5.4: Pneumococcal Disease
3.5.5: Influenza
3.5.6: Measles, Mumps, and Rubella (MMR)
3.5.7: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Pediatric Vaccine Market by Region
4.2: North American Pediatric Vaccine Market
4.2.1: North American Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
4.2.2: North American Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others
4.3: European Pediatric Vaccine Market
4.3.1: European Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
4.3.2: European Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others
4.4: APAC Pediatric Vaccine Market
4.4.1: APAC Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
4.4.2: APAC Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others
4.5: ROW Pediatric Vaccine Market
4.5.1: ROW Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
4.5.2: ROW Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Pediatric Vaccine Market by Vaccine Type
6.1.2: Growth Opportunities for the Global Pediatric Vaccine Market by Technology
6.1.3: Growth Opportunities for the Global Pediatric Vaccine Market by Application
6.1.4: Growth Opportunities for the Global Pediatric Vaccine Market by Region
6.2: Emerging Trends in the Global Pediatric Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Pediatric Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pediatric Vaccine Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: GlaxoSmithKline
7.2: Merck & Co
7.3: Sanofi
7.4: Pfizer
7.5: Johnson & Johnson
7.6: Bharat Biotech International
7.7: Serum Institute of India
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Pediatric Vaccine Market Report.